Cargando…

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model

[Image: see text] Estrogen receptor β (ERβ) selective agonists are considered potential therapeutic agents for a variety of pathological conditions, including several types of cancer. Their development is particularly challenging, since differences in the ligand binding cavities of the two ER subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paterni, Ilaria, Bertini, Simone, Granchi, Carlotta, Tuccinardi, Tiziano, Macchia, Marco, Martinelli, Adriano, Caligiuri, Isabella, Toffoli, Giuseppe, Rizzolio, Flavio, Carlson, Kathryn E., Katzenellenbogen, Benita S., Katzenellenbogen, John A., Minutolo, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2015
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610302/ https://www.ncbi.nlm.nih.gov/pubmed/25559213 http://dx.doi.org/10.1021/jm501829f

Ejemplares similares

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017)

Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
por: Poli, Giulio, et al.
Publicado: (2019)

Development and Validation of a Docking-Based Virtual Screening Platform for the Identification of New Lactate Dehydrogenase Inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2015)

Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
por: Poli, Giulio, et al.
Publicado: (2018)

Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors
por: Di Stefano, Miriana, et al.
Publicado: (2022)

Application of MM-PBSA Methods in Virtual Screening
por: Poli, Giulio, et al.
Publicado: (2020)

α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
por: Bononi, Giulia, et al.
Publicado: (2021)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy
por: Poli, Giulio, et al.
Publicado: (2021)

pRb controls Estrogen Receptor alpha protein stability and activity
por: Caligiuri, Isabella, et al.
Publicado: (2013)

A Guide to PIN1 Function and Mutations Across Cancers
por: El Boustani, Maguie, et al.
Publicado: (2019)

STARD3: A Prospective Target for Cancer Therapy
por: Asif, Kanwal, et al.
Publicado: (2021)

Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
por: Poli, Giulio, et al.
Publicado: (2017)

The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer
por: Lucchetti, Chiara, et al.
Publicado: (2013)

Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
por: Bononi, Giulia, et al.
Publicado: (2022)

Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
por: Tuccinardi, Tiziano, et al.
Publicado: (2019)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

Macrophage-Elicited Loss of Estrogen Receptor Alpha in Breast Cancer Cells via Involvement of MAPK and c-Jun at the ESR1 Genomic Locus
por: Stossi, Fabio, et al.
Publicado: (2011)

The structural pervasiveness of estrogenic activity.
por: Katzenellenbogen, J A
Publicado: (1995)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents †
por: D’Andrea, Felicia, et al.
Publicado: (2019)

Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives
por: Bononi, Giulia, et al.
Publicado: (2022)

OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies
por: Lapillo, Margherita, et al.
Publicado: (2019)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools
por: Palazzolo, Stefano, et al.
Publicado: (2020)

The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine
por: Bayda, Samer, et al.
Publicado: (2019)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

VenomPred: A Machine Learning Based Platform for Molecular Toxicity Predictions
por: Galati, Salvatore, et al.
Publicado: (2022)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gcb1r15ss9cpeg5tfil9soli9m